CRIS Current Research Information System

DALL'OLIO, FILIPPO GUSTAVO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.319
EU - Europa 1.105
AS - Asia 604
AF - Africa 92
OC - Oceania 4
Totale 3.124
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.315
IT - Italia 396
VN - Vietnam 222
SE - Svezia 172
GB - Regno Unito 151
SG - Singapore 148
DE - Germania 136
CN - Cina 132
IN - India 65
IE - Irlanda 49
TG - Togo 43
CH - Svizzera 42
RU - Federazione Russa 36
FR - Francia 26
FI - Finlandia 25
CI - Costa d'Avorio 19
JO - Giordania 18
NG - Nigeria 16
BG - Bulgaria 14
UA - Ucraina 12
AT - Austria 11
ZA - Sudafrica 11
EE - Estonia 9
BE - Belgio 6
ES - Italia 6
ID - Indonesia 5
NI - Nicaragua 4
PL - Polonia 4
AU - Australia 3
NL - Olanda 3
RO - Romania 3
HK - Hong Kong 2
IR - Iran 2
JP - Giappone 2
KR - Corea 2
PS - Palestinian Territory 2
PT - Portogallo 2
SC - Seychelles 2
TR - Turchia 2
EG - Egitto 1
HR - Croazia 1
LB - Libano 1
NZ - Nuova Zelanda 1
SK - Slovacchia (Repubblica Slovacca) 1
TW - Taiwan 1
Totale 3.124
Salva come PNG Salva come JPEG
Città #
Chandler 184
Dong Ket 140
Fairfield 138
Southend 135
Singapore 131
Ashburn 100
Santa Clara 92
Bologna 77
Seattle 76
Woodbridge 67
Houston 60
Wilmington 55
Princeton 51
Dublin 49
Lomé 43
Cambridge 41
Bern 35
Boardman 34
Rome 29
Helsinki 25
Milan 22
Beijing 20
Abidjan 19
Ann Arbor 19
Amman 18
Turin 18
Abeokuta 16
Berlin 16
Bremen 16
New York 16
Westminster 15
Sofia 14
San Diego 13
Florence 12
Redmond 12
Des Moines 11
Los Angeles 10
Nanjing 10
Jinan 9
Ravenna 9
Vienna 8
Moncalieri 7
Brussels 6
Changsha 6
Guangzhou 6
Redwood City 6
Torino 6
Brescia 5
Bühl 5
Frankfurt am Main 5
Olalla 5
Padova 5
Pune 5
Hyderabad 4
Kuban 4
Managua 4
Norwalk 4
Palermo 4
San Jose 4
Seville 4
Shenyang 4
Alghero 3
Chicago 3
Falls Church 3
Hangzhou 3
Jakarta 3
Las Vegas 3
London 3
Medford 3
Napoli 3
Saint Petersburg 3
Shanghai 3
Vigonza 3
Bari 2
Borgomanero 2
Cinisello Balsamo 2
Corbetta 2
Costa Mesa 2
Desio 2
Empoli 2
Falkenstein 2
Ferrara 2
Forlimpopoli 2
Fremont 2
Fuzhou 2
Gallipoli 2
Genoa 2
Goldach 2
Halhul 2
Hanoi 2
Hebei 2
Hong Kong 2
Jiaxing 2
Kunming 2
Leawood 2
Lecco 2
Licata 2
Livorno 2
Luzzara 2
Mahé 2
Totale 2.054
Salva come PNG Salva come JPEG
Nome #
Follow-up del cancro del pancreas esocrino 276
Adjuvant chemotherapy for resected colorectal cancer metastases: literature revision and meta-analysis 194
Comparison of Sequential Testing and Next Generation Sequencing in advanced Lung Adenocarcinoma patients – A single centre experience 194
CLINICOPATHOLOGICAL, MOLECULAR AND ONCOLOGICAL FEATURES OF SPORADIC EARLY ONSET COLORECTAL CANCERS 180
The 'surprise' question in advanced cancer patients: A prospective study among general practitioners. 176
Combined low densities of FoxP3+ and CD3+ tumor-infiltrating lymphocytes identify stage II colorectal cancer at high risk of progression 162
Arterial Embolization During Programmed Death-1 Inhibitor Treatment: An Unexpected Finding 147
CEA and CYFRA 21-1 as prognostic biomarker and as a tool for treatment monitoring in advanced NSCLC treated with immune checkpoint inhibitors 133
Clinical significance of ROS1 5’ deletions in non-small cell lung cancer 132
ECOG performance status ≥2 as a prognostic factor in patients with advanced non small cell lung cancer treated with immune checkpoint inhibitors—A systematic review and meta-analysis of real world data 124
Distinguishing between immune-related pneumonitis and disease progression in advanced Non Small Cell Lung Cancer treated with PD-1 inhibitors: Can serum tumour markers have a role? 115
The EGFR exon 19 mutant L747-A750>P exhibits distinct sensitivity to tyrosine kinase inhibitors in lung adenocarcinoma—letter 112
Correlation between MGMT promoter methylation and response to temozolomide-based therapy in neuroendocrine neoplasms: an observational retrospective multicenter study 107
Clinical and demographic factors associated to the place of death in advanced cancer patients assisted at home in Italy 93
Response to Osimertinib in Choroidal Metastases from EGFRmt T790M–Positive Non–Small Cell Lung Adenocarcinoma 92
Cardiac Toxicity From Afatinib in EGFR-Mutated NSCLC: A Rare But Possible Side Effect 91
Immortal time bias question in the association between toxicity and outcome of immune checkpoint inhibitors 85
Overcoming Primary Resistance to PD-1 Inhibitor With Anti–PD-L1 Agent in Squamous-Cell NSCLC: Case Report 83
Expected and non-expected immune-related adverse events detectable by CT 73
PD-L1 Expression in Circulating Tumor Cells as a Promising Prognostic Biomarker in Advanced Non–small-cell Lung Cancer Treated with Immune Checkpoint Inhibitors 73
Percutaneous radiofrequency ablation in intrahepatic cholangiocarcinoma: a retrospective single-center experience 71
Impact of HER2 assessment by CISH in urothelial carcinoma: A retrospective single-center experience 70
First-line pembrolizumab in advanced non–small cell lung cancer patients with poor performance status 67
Pneumatosis intestinalis and spontaneous perforation associated with drug toxicity in oncologic patients: A case series 65
Baseline total metabolic tumour volume on 2-deoxy-2-[18F]fluoro-d-glucose positron emission tomography-computed tomography as a promising biomarker in patients with advanced non-small cell lung cancer treated with first-line pembrolizumab. 62
Tumor growth rate decline despite progressive disease may predict improved nivolumab treatment outcome in mrcc: When recist is not enough 57
Monitoring tumor growth rate to predict immune checkpoint inhibitors' treatment outcome in advanced NSCLC 52
Quality of life assessment in renal cell carcinoma Phase II and III clinical trials published between 2010 and 2020: A systematic review 45
Role of PD-L1 assessment in advanced NSCLC: does it still matter? 40
Prognostic effect of body mass index in patients with advanced NSCLC treated with chemoimmunotherapy combinations 21
Immortal Time Bias Question in the Association Between Toxicity and Outcome of Immune Checkpoint Inhibitors 20
Antibiotic-exposed patients with non-small-cell lung cancer preserve efficacy outcomes following first-line chemo-immunotherapy 16
Totale 3.228
Salva come PNG Salva come JPEG
Categoria #
all - tutte 9.738
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.738
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020295 0 0 0 0 0 30 48 58 65 41 30 23
2020/2021545 45 16 23 6 69 40 8 23 41 27 10 237
2021/2022591 45 13 24 33 54 18 21 57 38 44 164 80
2022/2023839 60 148 53 99 65 63 26 53 127 18 57 70
2023/2024289 35 35 15 30 21 51 4 26 14 13 21 24
2024/2025476 70 113 73 54 127 39 0 0 0 0 0 0
Totale 3.228